🍂 Enjoy the Fall Season! 🍂
MindTheDesk

FDA Approves Pancreatic Cancer Drug That Nearly Doubled Survival In Trial

Top Story Archived • August 26, 2026 • 3 views
FDA Approves Pancreatic Cancer Drug That Nearly Doubled Survival In Trial
The U.S. Food and Drug Administration (FDA) on Wednesday approved a groundbreaking new treatment for advanced pancreatic cancer that nearly doubled median survival in a clinical trial, marking what experts are calling one of the biggest advances against the deadly disease in decades. The drug, daraxonrasib, which will be sold under the brand name Rasonque, ...
Source: Daily Wire | https://www.dailywire.com/feeds/rss.xml - Read Original
"Retirement Health Care"
"Get your business promoted today."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"